capAI PLC - Board and Committee Changes
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU, WHICH IS PART OF THE DOMESTIC LAW OF THE

capAI plc
(the "Company" or "capAI")
Board and Committee Changes
capAI plc (LSE: CPAI) is pleased to announce that
With immediate effect, Professor
|
Committee |
Chair |
Other members |
|
Audit & Risk Committee |
|
|
|
Disclosure Committee |
|
|
|
Nomination Committee |
|
|
|
Remuneration Committee |
|
|
The Company has accordingly granted options ("Options") over its ordinary shares of
|
Grant Date |
Exercise Price |
Number of Ordinary Shares |
Vesting Dates |
|
|
|
4,000,000 |
|
|
|
|
4,166,667 |
|
Comment
Professor
"We are delighted to announce the appointment of Jack, positioning capAI for further success as we move into the next exciting phase of growth.
As capAI's platforms move into commercial deployment, this marks an appropriate time to change the executive leadership of the Company and Jack will join the Board with immediate effect.
The capAI Board thanks Richard for his strategic insight and leadership over the last 14 months and we wish him well for the future."
Further information
No further information is required to be disclosed pursuant to the
Section 430 (2B) Companies Act 2006 statement
For the purposes of section 430(2B) of the Companies Act 2006, the Company confirms that
|
Grant Date |
Exercise Price |
Number of Ordinary Shares |
Vesting Dates |
|
|
|
12,500,000 ("March First Tranche") |
|
|
12,500,000 ("March Second Tranche") |
|
||
|
8,333,333 ("March Third Tranche") (out of 12,000,000, being the original total for the March Third Tranche) |
Accelerated vesting to 17 December (originally |
||
|
|
|
16,000,000 |
|
|
12,000,000 |
|
||
|
8,000,000 ("January Third Tranche") (out of 12,000,000, being the original total for the January Third Tranche) |
Accelerated vesting to 17 December (originally |
* Subject to the "Anti-Dilution Protection" that: in the event that the Company's outstanding warrants, which includes both those outstanding at the Grant Date and those issued pursuant to the fundraise announced by the Company via a RIS on
4,166,667 Ordinary Shares under the March Third Tranche of the March Option and 4,000,000 Ordinary Shares under the January Third Tranche of the January Option shall lapse on
The terms of the March Third Tranche of the March Option are amended such at the Anti-Dilution Protection shall not apply to this portion of the March Option (but shall apply to the March First Tranche and March Second Tranche of the March Option).
The Options have a two year exercise period from the date that
The Company's Remuneration Report for the financial year ending
For the purposes of
Enquiries
Company:
capAI plc hello@capaiplc.com
Broker:
AlbR Capital Limited Tel: +44 (0) 207 469 0930
Director's Dealing Notification
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||
|
a) |
Name |
|
||||||
|
2 |
Reason for Notification |
|||||||
|
a) |
Position/status |
Executive Director, PDMR (appointment effective |
||||||
|
b) |
Initial notification/amendment |
Initial notification |
||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
|
a) |
Name |
capAI plc |
||||||
|
b) |
LEI |
213800IVPZ932NP24O44 |
||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares |
||||||
|
|
Identification code |
|
||||||
|
b) |
Nature of the transaction |
Grant of share options |
||||||
|
c) |
Price(s) and volume(s) |
|
||||||
|
d) |
Aggregated information |
|
||||||
|
|
- Aggregated volume |
8,166,667 |
||||||
|
|
- Price |
£ 13,016.66 |
||||||
|
e) |
Date of the transaction |
|
||||||
|
f) |
Place of the transaction |
Outside a trading venue |
||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE